Abstract
Shedding of intercellular adhesion molecule 1 (ICAM-1) is believed to play a role in tumor cell resistance to cell-mediated cytotoxicity. However, the mechanism whereby ICAM-1 is shed from the surface of tumor cells remains unclear. In this study, we have addressed the possibility that matrix metalloproteinases are implicated in ICAM-1 shedding. Our observations suggest a functional relationship between ICAM-1 and matrix metalloproteinase 9 (MMP-9) whereby ICAM-1 provides a cell surface docking mechanism for proMMP-9, which, upon activation, proteolytically cleaves the extracellular domain of ICAM-1 leading to its release from the cell surface. MMP-9-dependent shedding of ICAM-1 is found to augment tumor cell resistance to natural killer (NK) cell-mediated cytotoxicity. Taken together, our observations propose a mechanism for ICAM-1 shedding from the cell surface and provide support for MMP involvement in tumor cell evasion of immune surveillance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M . 1993 Cancer Res. 53: 3343–3348
Aoudjit F, Potworowski EF, St-Pierre Y . 1998 J. Immunol. 160: 2967–2973
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B . 1990 Cell 61: 1303–1313
Becker JC, Brocker EB . 1995 Recent Results Cancer Res. 139: 205–214
Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE . 1991 J. Immunol. 147: 4398–4401
Bergers G, Coussens LM . 2000 Curr. Opin. Genet. Dev. 10: 120–127
Bernhard EJ, Gruber SB, Muschel RJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4293–4297
Bernhard EJ, Muschel RJ, Hughes EN . 1990 Cancer Res. 50: 3872–3877
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA . 1993 Crit. Rev. Oral Biol. Med. 4: 197–250
Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA . 1996 Cell 85: 683–693
Fonsatti E, Altomonte M, Coral S, Cattarossi I, Nicotra MR, Gasparollo A, Natali PG, Maio M . 1997 Br. J. Cancer 76: 1255–1261
Gong JH, Maki G, Klingemann HG . 1994 Leukemia 8: 652–658
Grothey A, Heistermann P, Philippou S, Voigtmann R . 1998 Br. J. Cancer 77: 801–807
Gu B, Bendall LJ, Wiley JS . 1998 Blood 92: 946–951
Guo H, Li R, Zucker S, Toole BP . 2000 Cancer Res. 60: 888–891
Hafezi-Moghadam A, Thomas KL, Prorock AJ, Huo Y, Ley K . 2001 J. Exp. Med. 193: 863–872
Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R . 1991 Cancer Res. 51: 5003–5005
Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z . 1986 J. Biol. Chem. 261: 2814–2818
Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ . 2000 J. Cell. Biol. 149: 1309–1323
Huang HY, Wen Y, Irwin JC, Kruessel JS, Soong YK, Polan ML . 1998 J. Clin. Endocrinol. Metab. 83: 1721–1729
Hynes RO, Lander AD . 1992 Cell 68: 303–322
Ismair MG, Ries C, Lottspeich F, Zang C, Kolb HJ, Petrides PE . 1998 Leukemia 12: 1136–1143
Kleiner DE, Stetler-Stevenson WG . 1999 Cancer Chemother. Pharmacol. 43: Suppl S42–S51
Kondapaka SB, Fridman R, Reddy KB . 1997 Int. J. Cancer 70: 722–726
Kridel SJ, Chen E, Kotra LP, Howard EW, Mobashery S, Smith JW . 2001 J. Biol. Chem. 276: 20572–20578
Lyons PD, Benveniste EN . 1998 Glia 22: 103–112
Makgoba MW, Sanders ME, Ginther Luce GE, Dustin ML, Springer TA, Clark EA, Mannoni P, Shaw S . 1988 Nature 331: 86–88
Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P . 1997 EMBO J. 16: 2319–2332
Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I . 2000 Cancer Res. 60: 4122–4129
Nagase H, Woessner Jr JF . 1999 J. Biol. Chem. 274: 21491–21494
Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M, Suga M, Ando M, Nakajima M, Saya H . 1999 Oncogene 18: 1435–1446
Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R . 1998 J. Biol. Chem. 273: 10672–10681
Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G . 1998 Nature 392: 190–193
Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA . 1998 Science 282: 1281–1284
Pizzolo G, Vinante F, Nadali G, Ricetti MM, Morosato L, Marrocchella R, Vincenzi C, Semenzato G, Chilosi M . 1993 Br. J. Haematol. 84: 161–162
Sanchez-Rovira P, Jimenez E, Carracedo J, Barneto IC, Ramirez R, Aranda E . 1998 Eur. J. Cancer 34: 394–398
Shapiro SD . 1998 Curr. Opin. Cell Biol. 10: 602–608
Springer TA . 1990 Annu. Rev. Cell Biol. 6: 359–402
Springer TA . 1994 Cell 76: 301–314
Stamenkovic I . 2000 Semin. Cancer Biol. 10: 415–433
Stamenkovic I, Seed B . 1990 Nature 345: 74–77
Tam YK, Maki G, Miyagawa B, Hennemann B, Tonn T, Klingemann HG . 1999 Hum. Gene Ther. 10: 1359–1373
Toth M, Gervasi DC, Fridman R . 1997 Cancer Res. 57: 3159–3167
Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z . 1998 Cell 93: 411–422
Werb Z . 1997 Cell 91: 439–442
Yu Q, Stamenkovic I . 1999 Genes Dev. 13: 35–48
Yu Q, Stamenkovic I . 2000 Genes Dev. 14: 163–176
Yu WH, Woessner Jr JF . 2000 J. Biol. Chem. 275: 4183–4191
Zhao L, Shey M, Farnsworth M, Dailey MO . 2001 J. Biol. Chem. 276: 30631–30640
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fiore, E., Fusco, C., Romero, P. et al. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21, 5213–5223 (2002). https://doi.org/10.1038/sj.onc.1205684
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205684
Keywords
This article is cited by
-
MMP-9 reinforces radiation-induced delayed invasion and metastasis of neuroblastoma cells through second-signaling positive feedback with NFκB via both ERK and IKK activation
Cell Biology and Toxicology (2023)
-
Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke
Translational Stroke Research (2022)
-
Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells
Japanese Journal of Ophthalmology (2018)
-
The association between blood glucose levels and matrix-metalloproteinase-9 in early severe sepsis and septic shock
Journal of Inflammation (2016)
-
Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
Scientific Reports (2016)